ANCA vasculitis presenting with acute interstitial nephritis without glomerular involvement

Callie Plafkin, Weixiong Zhong, T. Singh
{"title":"ANCA vasculitis presenting with acute interstitial nephritis without glomerular involvement","authors":"Callie Plafkin, Weixiong Zhong, T. Singh","doi":"10.5414/CNCS109805","DOIUrl":null,"url":null,"abstract":"ANCA-associated vasculitis (AAV) with renal involvement typically causes pauci-immune glomerulonephritis. We present a case of acute interstitial nephritis (AIN) as the sole renal lesion without glomerulonephritis with myeloperoxidase (MPO) AAV. A 45-year-old female with history of Crohn’s disease, gastroesophageal reflux disease (GERD) with Barrett’s esophagus, pulmonary embolism, and polyarthralgias was evaluated in nephrology clinic in 2018. AIN without glomerulonephritis was first diagnosed in 2011 on renal biopsy. p-ANCA was positive with MPO titer of > 100 U/mL. Serum creatinine improved from 2.1 to 0.9 mg/dL with prednisone and azathioprine. Repeat biopsy in 2013 for worsening renal function showed AIN without glomerular involvement. Serum creatinine improved from 1.9 to 1.2 mg/dL with prednisone and cyclosporine. Crohn’s disease was diagnosed in 2014. AIN was attributed to Crohn’s, and cyclosporine was stopped in 2016. Adalimumab was started in 2016, without improvement in renal function or urine sediment. Attempt was made to switch proton pump inhibitor (PPI) to H2-blocker, but the latter was not tolerated. Repeat biopsy in 2/2018 showed AIN with severe fibrosis and tubular atrophy and glomerulosclerosis but no active glomerular disease. MPO titers remained high at 132 U/mL. Mycophenolic acid and prednisone were started without response, followed by rituximab for AAV-associated AIN. Serum creatinine worsened to 6.0 mg/dL in 9/2018, with plan to start peritoneal dialysis. AAV may present with isolated AIN without glomerular involvement. The rarity of this presentation may contribute to delay in appropriate management. Alternative explanations for AIN, such as Crohn’s disease or PPI use should be considered with caution in the setting of high-titer ANCA positivity.","PeriodicalId":10398,"journal":{"name":"Clinical Nephrology. Case Studies","volume":"11 1","pages":"46 - 50"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Nephrology. Case Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5414/CNCS109805","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

Abstract

ANCA-associated vasculitis (AAV) with renal involvement typically causes pauci-immune glomerulonephritis. We present a case of acute interstitial nephritis (AIN) as the sole renal lesion without glomerulonephritis with myeloperoxidase (MPO) AAV. A 45-year-old female with history of Crohn’s disease, gastroesophageal reflux disease (GERD) with Barrett’s esophagus, pulmonary embolism, and polyarthralgias was evaluated in nephrology clinic in 2018. AIN without glomerulonephritis was first diagnosed in 2011 on renal biopsy. p-ANCA was positive with MPO titer of > 100 U/mL. Serum creatinine improved from 2.1 to 0.9 mg/dL with prednisone and azathioprine. Repeat biopsy in 2013 for worsening renal function showed AIN without glomerular involvement. Serum creatinine improved from 1.9 to 1.2 mg/dL with prednisone and cyclosporine. Crohn’s disease was diagnosed in 2014. AIN was attributed to Crohn’s, and cyclosporine was stopped in 2016. Adalimumab was started in 2016, without improvement in renal function or urine sediment. Attempt was made to switch proton pump inhibitor (PPI) to H2-blocker, but the latter was not tolerated. Repeat biopsy in 2/2018 showed AIN with severe fibrosis and tubular atrophy and glomerulosclerosis but no active glomerular disease. MPO titers remained high at 132 U/mL. Mycophenolic acid and prednisone were started without response, followed by rituximab for AAV-associated AIN. Serum creatinine worsened to 6.0 mg/dL in 9/2018, with plan to start peritoneal dialysis. AAV may present with isolated AIN without glomerular involvement. The rarity of this presentation may contribute to delay in appropriate management. Alternative explanations for AIN, such as Crohn’s disease or PPI use should be considered with caution in the setting of high-titer ANCA positivity.
ANCA血管炎表现为急性间质性肾炎,不累及肾小球
anca相关性血管炎(AAV)累及肾脏,通常会导致少免疫肾小球肾炎。我们报告一例急性间质性肾炎(AIN)作为唯一的肾脏病变,没有肾小球肾炎伴髓过氧化物酶(MPO) AAV。2018年在肾内科门诊评估了一名45岁女性,有克罗恩病、胃食管反流病(GERD)合并Barrett食管、肺栓塞、多关节痛病史。AIN合并肾小球肾炎于2011年首次通过肾活检确诊。p-ANCA阳性,MPO滴度> 100 U/mL。强的松和硫唑嘌呤使血清肌酐从2.1 mg/dL提高到0.9 mg/dL。2013年因肾功能恶化再次活检显示AIN未累及肾小球。强的松和环孢素使血清肌酐从1.9 mg/dL提高到1.2 mg/dL。克罗恩病于2014年被诊断出来。AIN被归因于克罗恩病,环孢素在2016年被停用。阿达木单抗于2016年开始使用,没有改善肾功能或尿沉淀。尝试将质子泵抑制剂(PPI)转换为h2阻滞剂,但后者不耐受。2018年2月复查活检显示AIN伴严重纤维化、小管萎缩和肾小球硬化,但无活动性肾小球疾病。MPO滴度保持在132 U/mL。开始使用麦考酚酸和强的松无反应,随后使用利妥昔单抗治疗aav相关的AIN。2018年9月血清肌酐恶化至6.0 mg/dL,计划开始腹膜透析。AAV可表现为孤立性AIN,不累及肾小球。这种罕见的表现可能会延误适当的管理。在高滴度ANCA阳性的情况下,应谨慎考虑AIN的其他解释,如克罗恩病或使用PPI。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信